Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-17
DOI
10.1038/s41585-022-00638-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trends in Incidence of Metastatic Prostate Cancer in the US
- (2022) Mihir M. Desai et al. JAMA Network Open
- Association of reductions in PSA screening across states with increased metastatic prostate cancer in the United States.
- (2021) Vidit Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
- (2021) Thomas Callender et al. JAMA Network Open
- Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial
- (2021) Jonas Wallström et al. EUROPEAN RADIOLOGY
- Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021
- (2021) Hendrik Van Poppel et al. EUROPEAN UROLOGY
- MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
- (2021) Martin Eklund et al. NEW ENGLAND JOURNAL OF MEDICINE
- Artificial Intelligence Based Algorithms for Prostate Cancer Classification and Detection on Magnetic Resonance Imaging: A Narrative Review
- (2021) Jasper J. Twilt et al. Diagnostics
- Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future?
- (2021) Monique J. Roobol Translational Andrology and Urology
- Active surveillance for prostate cancer
- (2021) Daniela K. Shill et al. Translational Andrology and Urology
- Predictive Factors of Missed Clinically Significant Prostate Cancers in Men with Negative MRI: A Systematic Review and Meta-Analysis
- (2020) MA Pagniez et al. JOURNAL OF UROLOGY
- Opportunistic prostate cancer screening: A population-based analysis
- (2020) Bashar Matti et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- European cancer mortality predictions for the year 2020 with a focus on prostate cancer
- (2020) G. Carioli et al. ANNALS OF ONCOLOGY
- Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment
- (2020) Eboneé N. Butler et al. BRITISH JOURNAL OF CANCER
- Personalized strategies in population screening for prostate cancer
- (2020) Sebastiaan Remmers et al. INTERNATIONAL JOURNAL OF CANCER
- Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening
- (2020) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Reconsidering Prostate Cancer Mortality — The Future of PSA Screening
- (2020) H. Gilbert Welch et al. NEW ENGLAND JOURNAL OF MEDICINE
- A discussion on controversies and ethical dilemmas in prostate cancer screening
- (2020) Satish Chandra Mishra JOURNAL OF MEDICAL ETHICS
- Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators
- (2020) Ashkan Mortezavi et al. European Urology Focus
- Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies
- (2020) Juha Knaapila et al. European Urology Focus
- Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
- (2020) Abraham M. Getaneh et al. Cancer Medicine
- Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017
- (2020) David A. Siegel et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998–2017
- (2020) Ashley Kieran Clift et al. BRITISH JOURNAL OF GENERAL PRACTICE
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2020) Nicolas Mottet et al. EUROPEAN UROLOGY
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
- (2019) Jonas Hugosson et al. EUROPEAN UROLOGY
- Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
- (2019) Daniël Osses et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Early detection of prostate cancer using prostate-specific antigen testing: an empirical evaluation among general practitioners and urologists
- (2019) Sanny Kappen et al. Cancer Management and Research
- Multiparametric MRI for prostate cancer diagnosis: current status and future directions
- (2019) Armando Stabile et al. Nature Reviews Urology
- Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)
- (2019) Xavier Rossello et al. European Journal of Preventive Cardiology
- Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
- (2019) MaryBeth B. Culp et al. EUROPEAN UROLOGY
- Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
- (2019) Salim Yusuf et al. LANCET
- Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine
- (2019) Ausvydas Patasius et al. BMJ Open
- Changing Incidence and Stage Distribution of Prostate Cancer in a Lithuanian Population—Evidence from National PSA-Based Screening Program
- (2019) Ausvydas Patasius et al. International Journal of Environmental Research and Public Health
- Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models
- (2018) Sabina Sanghera et al. BMC CANCER
- Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality
- (2018) Richard M. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quality of Health Care for Children
- (2018) David C. Grossman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate
- (2018) Tim Ullrich et al. JOURNAL OF UROLOGY
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators
- (2018) Arnout R. Alberts et al. EUROPEAN UROLOGY
- Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
- (2018) Dragan Ilic et al. BMJ-British Medical Journal
- Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
- (2018) Kari A O Tikkinen et al. BMJ-British Medical Journal
- Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial
- (2018) Paul F. Pinsky et al. BJU INTERNATIONAL
- Prospective evaluation on the effect of interobserver variability of digital rectal examination on the performance of the Rotterdam Prostate Cancer Risk Calculator
- (2017) Nuno Pereira-Azevedo et al. INTERNATIONAL JOURNAL OF UROLOGY
- Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
- (2017) Tobias Nordström et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality
- (2017) Jonas Hugosson et al. Scandinavian Journal of Urology
- Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis
- (2016) Sigrid V. Carlsson et al. CANCER
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
- (2016) Jeffrey C. Weinreb et al. EUROPEAN UROLOGY
- The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA
- (2016) Katherine Fleshner et al. Nature Reviews Urology
- Reevaluating PSA Testing Rates in the PLCO Trial
- (2016) Jonathan E. Shoag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities
- (2016) Idris Guessous et al. PREVENTIVE MEDICINE
- Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies
- (2016) Joshua A. Roth et al. JAMA Oncology
- Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial
- (2015) Rebecka Arnsrud Godtman et al. EUROPEAN UROLOGY
- Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States
- (2015) Ayal A. Aizer et al. Journal of the National Comprehensive Cancer Network
- Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
- (2015) Henrik Grönberg et al. LANCET ONCOLOGY
- Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study
- (2015) K. Pickles et al. BMJ Open
- Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
- (2014) K. S. Louie et al. ANNALS OF ONCOLOGY
- Overdiagnosis and Overtreatment of Prostate Cancer
- (2014) Stacy Loeb et al. EUROPEAN UROLOGY
- Rescreening policies and risk calculators
- (2014) Monique J. Roobol Nature Reviews Urology
- Twelve myths about shared decision making
- (2014) France Légaré et al. PATIENT EDUCATION AND COUNSELING
- Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer
- (2014) Donna P. Ankerst et al. UROLOGY
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) ANNALS OF INTERNAL MEDICINE
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Early Detection of Prostate Cancer: European Association of Urology Recommendation
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Cost-effectiveness of Magnetic Resonance (MR) Imaging and MR-guided Targeted Biopsy Versus Systematic Transrectal Ultrasound–Guided Biopsy in Diagnosing Prostate Cancer: A Modelling Study from a Health Care Perspective
- (2013) Maarten de Rooij et al. EUROPEAN UROLOGY
- Early Detection of Prostate Cancer: AUA Guideline
- (2013) H. Ballentine Carter et al. JOURNAL OF UROLOGY
- The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer?
- (2013) Mohamed Abd-Alazeez et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
- (2012) Fritz H. Schröder et al. EUROPEAN UROLOGY
- Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion
- (2012) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Quality-of-Life Effects of Prostate-Specific Antigen Screening
- (2012) Eveline A.M. Heijnsdijk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators
- (2011) Monique J. Roobol et al. EUROPEAN UROLOGY
- American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
- (2010) A. M. D. Wolf et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
- (2010) Paul F Pinsky et al. Clinical Trials
- ERSPC and PLCO Prostate Cancer Screening Studies: What Are the Differences?
- (2010) Fritz H. Schröder et al. EUROPEAN UROLOGY
- Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
- (2010) Flip H. Jansen et al. EUROPEAN UROLOGY
- Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners
- (2009) Frances J Drummond et al. BMC Family Practice
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
- (2008) Andrew J Vickers et al. BMC Medicine
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started